MoneyWorks4Me

Mesco Pharmaceuticals informs about outcome of board meeting

12 Nov 2021 Evaluate
Mesco Pharmaceuticals has informed that the board at its meeting held on 12th November 2021 considered and approved the Un-Audited Financial Results for Quarter ended on 30th September, 2021 as per Regulation 33(3) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 along with the Limited Review Report.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..